Dr Jessica Taylor

University of Cambridge

University departments
Cancer Research UK Cambridge Institute
University institutes
CRUK Cambridge Institute
NHS or other affiliations
Emmanuel College, Roger Ekins Fellow

Position: Research Associate
Personal home page: @plantpoweredpostdoc
Email:   jessica.taylor@cruk.cam.ac.uk

PubMed journal articles - click here

Research Programme or Virtual Institute
Brain Cancer Virtual Institute
Secondary Programme
Paediatric Cancer
Strategic Resources
CRUK RadNet Cambridge
Recent publications:
 Retrieving latest data from feed...

Symplectic Elements feed provided by Research Information, University of Cambridge

Key publications

Taylor JT, Ellison S, Pandele A, Wood S, Nathan E, Forte G, Parker H, Zindy E, Elvin M, Dickson A, Williams KJ, Karabatsou K, McCabe M, McBain C, Bigger BW. Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastoma. Neuro Oncol. 2020 Sep 29;22(9):1289-1301. doi: 10.1093/neuonc/noaa051. PMID: 32227096; PMCID: PMC7523458.

Green D, Eyre H, Singh A, Taylor JT, Chu J, Jeys L, Sumathi V, Coonar A, Rassl D, Babur M, Forster D, Alzabin S, Ponthan F, McMahon A, Bigger B, Reekie T, Kassiou M, Williams K, Dalmay T, Fraser WD, Finegan KG. Targeting the MAPK7/MMP9 axis for metastasis in primary bone cancer. Oncogene. 2020 Aug;39(33):5553-5569. doi: 10.1038/s41388-020-1379-0. Epub 2020 Jul 13. PMID: 32655131; PMCID: PMC7426263.

Yu KK*, Taylor JT*, Pathmanaban ON, Youshani AS, Beyit D, Dutko-Gwozdz J, Benson R, Griffiths G, Peers I, Cueppens P, Telfer BA, Williams KJ, McBain C, Kamaly-Asl ID, Bigger BW. High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma. PLoS One. 2018 Mar 2;13(3):e0193694. doi: 10.1371/journal.pone.0193694. PMID: 29499065; PMCID: PMC5834163.